ERBB2 and central nervous system cancer: In another trial, 3 young adults aged 19 to 26 who were diagnosed with glioma as children were treated with weekly infusions of HER2-CAR-T cells for 4 weeks.50 Two patients received intraventricular treatment and 1 received intracavitary treatment, without prior lymphodepletion.